长风药业股份有限公司（股票代码：02652）于2026年5月11日发布公告，披露该公司近日在香港联交所场内回购股份。
本次回购于2026年5月11日进行，共回购8,500股，占当日公司已发行股本约0.0028%。回购价格区间介乎每股21.80港元至22.00港元，支付总金额约18.64万港元。回购完成后，公司已发行股本为301,516,086股，库存股数量为707,500股。
上述回购基于公司于2025年12月16日获股东大会批准的股份回购授权，授权总数为30,222,358股。截至目前，公司已在香港联交所及其他证券交易所合计回购707,500股。公司确认，已遵守香港联合交易所有限公司的相关上市规则及法律规定。
本公告由公司执行董事及联席公司秘书朱玉玉签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.